Disclaimer:

Disclaimer: The blog posts and comments on this blog and posts on social networks are not investment recommendation, are provided solely for informational purposes, and do not constitute an offer or solicitation to buy or sell any securities. The opinions expressed on the blog are Petar Posledovich's. Petar Posledovich does not guarantee the accuracy of the information presented on this blog and social networks. The information presented is "as is". The blog is stocks analysis and valuation, Bitcoin, Cryptocurrencies, Artificial Intelligence, AI, deep-learning focused. Independent, unbiased AI insights. Petar Vladimirov Posledovich is not liable for any investment losses incurred by reading and interpreting blog posts on this blog and posts on social networks. Conflicts of interest: I may possess some of the securities, currencies or their derivatives mentioned in the blog post and posts on social networks! The blog is property of Wolfteam Ltd. www.wolfteamedge.com Respectfully yours, Petar Posledovich

Wednesday, February 25, 2026

Blue Owl Raises 1.4 Billion USDs To Pay Off Redemptions

 


Blue Owl Capital Inc or Blue Owl announced last week it holds clients redemptions from its OBDC II fund.

OBDC II had a redemption limit of 5 % a month. Blue Owl announced last week it would pay off 30 % to investors in OBDC II instead.

The Blue Owl 1.4 billions USD asset sales is to four leading North American public pension and insurance investors.

With the 1.4 billion USD asset sale Blue Owl aims to calm investors as to the state of the private credit asset managers and especially their exposure to software companies.

18 % of private equity, private credit deal making in 2025 consisted of technology companies.

As a consequence of software and technology exposure value the leading private equity, private credit markets companies' market capitalization fell circa 30 % from their recent peaks  

Blue Owl should recover along with the rest of the technology sectors in 2-3 years, according to Wolfteam Ltd.'s projections and estimates.

 

No comments: